Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Short-term Investments (2019 - 2022)

Historic Short-term Investments for TransMedics (TMDX) over the last 4 years, with Q2 2022 value amounting to $27.7 million.

  • TransMedics' Short-term Investments fell 6814.06% to $27.7 million in Q2 2022 from the same period last year, while for Jun 2022 it was $27.7 million, marking a year-over-year decrease of 6814.06%. This contributed to the annual value of $66.9 million for FY2021, which is 3383.01% down from last year.
  • Per TransMedics' latest filing, its Short-term Investments stood at $27.7 million for Q2 2022, which was down 6814.06% from $54.1 million recorded in Q1 2022.
  • In the past 5 years, TransMedics' Short-term Investments registered a high of $111.3 million during Q3 2020, and its lowest value of $27.7 million during Q2 2022.
  • For the 4-year period, TransMedics' Short-term Investments averaged around $71.8 million, with its median value being $67.9 million (2019).
  • Per our database at Business Quant, TransMedics' Short-term Investments skyrocketed by 9112.01% in 2021 and then crashed by 6814.06% in 2022.
  • Over the past 4 years, TransMedics' Short-term Investments (Quarter) stood at $60.6 million in 2019, then surged by 66.78% to $101.1 million in 2020, then crashed by 33.83% to $66.9 million in 2021, then crashed by 58.58% to $27.7 million in 2022.
  • Its Short-term Investments stands at $27.7 million for Q2 2022, versus $54.1 million for Q1 2022 and $66.9 million for Q4 2021.